Nguyen TMX , Vegrichtova M , Tlapakova T , Krulova M , Krylov V .

	Figure 1. Scheme of the incubation chamber for the directed migration of XtiSCs towards cancer HeLa cells. XtiSCs were placed into lower part of the incubation chamber containing 100 μl of FGF2-, CHIR99021-, or 0.1% DMSO-supplemented media. After three-day treatment, inducing or control (0.1% DMSO) medium was replaced by 120 μl of standard cultivation medium supplemented with PLMatrix. HeLa or HEK cell suspension (control) was added to the upper part after the solidifying of PLMatrix. HeLa cells are separated from XtiSCs by the detection zone.
	Figure 2. (a) Testicular cross-sections from juvenile Xenopus tropicalis stained with two antibodies, cytokeratin (green)/Sox9 (red, SC marker) and vimentin (green)/Sox9. Thin arrows show migrating Sertoli cells (SCs) or pre-SCs outside the seminiferous tubules. Thick arrows indicate SCs inside the tubules. Cytokeratin is absent in pre-SCs, in contrast to tubular SCs. On the other hand, vimentin is present in both types, migrating and tubular SCs. (b) Double staining of testicular cross-sections with two antibodies, cytokeratin (green)/Sox9 (red) and vimentin (green)/Sox9 from adult Xenopus tropicalis. The only vimentin is observed in Sox9 nuclear-expressing SCs. ( continued)
	Figure 2 (continued) (c) Immunofluorescent staining of XtiSCs with antibodies against cytokeratin (green)/Sox9 (red) shows that most of the XtiSCs expressed both proteins which evidence them as immature Sertoli cells or SC progenitors. The expression of vimentin was observed in XtiSCs as well. Nuclei were stained with DAPI. Scale bar: 50 μm. (d) The scheme illustrates the development of Sertoli cells in testis.
	Figure 3: GSK-3 inhibitor (CHIR99021) stimulates EMT in XtiSC cell culture. XtiSCs were cultured in a growth medium supplemented with 25 ng/ml FGF2 or 3 μM CHIR99021 or 0.1% DMSO as a control. (a) After three-day treatment, the morphological change of XtiSCs from cobblestone shape to a long-rod shape in a medium with CHIR99021 was observed. Scale bar: 100 μm.
	Figure 3 (continued) (b, c) Immunofluorescent staining and RT-PCR analysis showed the downregulation of epithelial markers (cytokeratin, β-catenin at the plasma cell membrane) (b) and the increase of mesenchymal markers (fibronectin, integrin α5β1, Snai1, and twist1) (c, d). Arrows show the expression of β-catenin at the plasma cell membrane. Nuclei stained with DAPI. Scale bar: 20 μm. Results are representative of three biological replicates; *p <0.5 ** p< 0.001.
	Figure 3: (continued) (c, d). Arrows show the expression of β-catenin at the plasma cell membrane. Nuclei stained with DAPI. Scale bar: 20 μm. Results are representative of three biological replicates; *p <0.5 ** p< 0.001.
	Figure 4. Gene expression of mesenchymal stem cell markers in FGF2- and CHIR99021-treated XtiSCs. Immunofluorescent staining (a) and RT-PCR (b) show the increased expression of stem cell markers, Sox2, cd44, and Zeb1 after FGF2 and CHIR99021 treatments. However, only CHIR-treated XtiSCs suppressed Acta2, the earliest marker of mural cell progenitors. RT: reverse transcriptase. Scale bar: 20 μm. Nuclei stained with DAPI. Results are representative of three biological replicates; ∗∗ p < 0.01.
	Figure 5. In vitro differentiation of XtiSCs. XtiSCs were treated with FGF2, CHIR99021, or 0.1% DMSO as a control for 3-4 days followed by the replacement of medium with osteogenic and chondrogenic induction media. (a) Osteocyte differentiation of XtiSCs was evidenced as a calcium deposit reacting with alizarin red (A). Cells were lysed at low pH to release alizarin red dye from the stained monolayer for a colorimetric test as illustrated in diagram (B). (b) Alcian blue was used to stain glycosaminoglycans in cartilages. In the control (untreated cells), the dye reacts only with the periphery of cell clusters. On the other hand, alcian blue staining is strong and uniform in XtiSC clumps after FGF2 and CHIR99021 treatments, indicating the high level of proteoglycan forming the extracellular matrix. However, collagen type II, a specific marker of the cartilage matrix, was expressed in cells pretreated with CHIR99021 only. DAPI was used as cell counterstains. Results are representative of three biological replicates. Scale bar: 100 μm for bright field images and 50 μm for fluorescent images (lower panel of (b)); ∗ p < 0.005, ∗∗ p < 0.001.
	Figure 6. Directed migration of XtiSCs towards cancer HeLa cells. Control XtiSCs or XtiSCs treated with FGF2 or CHIR 99021 were placed into lower part of the incubation chamber as described in Figure 1. After 36-48 hours, the number of cells in the detection zone was counted and expressed in the chart (a). The results are representative of five biological replicates. ∗∗ p < 0.01. XtiSCs captured in the detection zone are seen in (b).
	Figure 7. In vivo differentiation of EMT-induced XtiSCs into cardiomyocytes. (a) Experimental scheme. RFP-positive XtiSCs were cultured in a growth medium supplemented with 3 μM CHIR99021 or 0.1% DMSO as a control for 3-4 days before transplantation into 2-day-old tadpoles. (b) At 4th, 14th, or 30th day postinjection (dpi), tadpoles were fixed and sectioned for double staining with antibodies against red fluorescent protein and cardiac troponin T labeling cardiomyocytes in the heart. Scale bar: 20 μm. Nuclei stained with DAPI. Results are representative of four biological replicates.
	Figure 8. In vivo migration of untreated or CHIR99021-treated XtiSCs transplanted into the dorsal veins of 3-week-old tadpoles towards skin injury. (a) Differential migration behavior of untreated and treated RFP-expressing XtiSCs inside wounded or unwounded tadpoles. Arrows show the migrating RFP-positive XtiSCs; thick arrows indicate the injection sites. The injury site is marked by a black asterisk. Scale bar: 500 μm. ( continued)
	Figure 8. (continued) (b) The distance of leading cells from the injection site was measured 6 hours after transplantation by ImageJ and expressed in the chart. (c) Two days after transplantation, fibronectin was detected in untreated XtiSCs at the injury site only but not in cells outside wounded areas in both groups. Results are representative of three biological replicates. Nuclei were stained with DAPI. Scale bar: 20 μm; ∗p < 0.05, ∗∗p < 0.01.
	Figure 9. The representative fluorescent images of STAT3 expression in XtiSCs in different medium cultures of three biological replicates. The STAT3 upregulation is observed in FGF2-treated cells. On the other hand, CHIR99021 is responsible for its downregulation. Results are representative of three biological replicates. Nuclei were stained with DAPI. Scale bar: 20 μm

Albrecht, Evidence that Sry is expressed in pre-Sertoli cells and Sertoli and granulosa cells have a common precursor. 2001, Pubmed

Albrecht, Evidence that Sry is expressed in pre-Sertoli cells and Sertoli and granulosa cells have a common precursor. 2001, Pubmed
Appert, Patterns of keratins 8, 18 and 19 during gonadal differentiation in the mouse: sex- and time-dependent expression of keratin 19. 1998, Pubmed
Baljinnyam, Epac1 increases migration of endothelial cells and melanoma cells via FGF2-mediated paracrine signaling. 2014, Pubmed
Barrionuevo, Origin and function of embryonic Sertoli cells. 2011, Pubmed
Battula, Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells. 2010, Pubmed
Ben Amar, Re-epithelialization: advancing epithelium frontier during wound healing. 2014, Pubmed
Beurel, Differential regulation of STAT family members by glycogen synthase kinase-3. 2008, Pubmed
Brabletz, The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells. 2011, Pubmed
Brown, Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro. 2004, Pubmed
Chen, Pre-activation of mesenchymal stem cells with TNF-α, IL-1β and nitric oxide enhances its paracrine effects on radiation-induced intestinal injury. 2015, Pubmed
Ciruna, FGF signaling regulates mesoderm cell fate specification and morphogenetic movement at the primitive streak. 2001, Pubmed
Croes, Proinflammatory Mediators Enhance the Osteogenesis of Human Mesenchymal Stem Cells after Lineage Commitment. 2015, Pubmed
Câmara, Epithelial-mesenchymal transition in primary human bronchial epithelial cells is Smad-dependent and enhanced by fibronectin and TNF-alpha. 2010, Pubmed
Egea, TNF-α respecifies human mesenchymal stem cells to a neural fate and promotes migration toward experimental glioma. 2011, Pubmed
Geach, Developmental genetics in Xenopus tropicalis. 2011, Pubmed , Xenbase
Greco, High density micromass cultures of a human chondrocyte cell line: a reliable assay system to reveal the modulatory functions of pharmacological agents. 2011, Pubmed
Hemendinger, Identification of a specific Sertoli cell marker, Sox9, for use in transplantation. 2002, Pubmed
Jolly, Towards elucidating the connection between epithelial-mesenchymal transitions and stemness. 2014, Pubmed
Kalluri, The basics of epithelial-mesenchymal transition. 2009, Pubmed
Karl, Sertoli cells of the mouse testis originate from the coelomic epithelium. 1998, Pubmed
Kwon, Tumor necrosis factor-α-activated mesenchymal stem cells promote endothelial progenitor cell homing and angiogenesis. 2013, Pubmed
Lamouille, Molecular mechanisms of epithelial-mesenchymal transition. 2014, Pubmed
Lee, Signal transducer and activator of transcription 3 (STAT3) protein suppresses adenoma-to-carcinoma transition in Apcmin/+ mice via regulation of Snail-1 (SNAI) protein stability. 2012, Pubmed
Li, Evidence for mesenchymal-epithelial transition associated with mouse hepatic stem cell differentiation. 2011, Pubmed
Lustig, Immunodetection of cell adhesion molecules in rat Sertoli cell cultures. 1998, Pubmed
Mani, The epithelial-mesenchymal transition generates cells with properties of stem cells. 2008, Pubmed
Nakaya, Mesenchymal-epithelial transition during somitic segmentation is regulated by differential roles of Cdc42 and Rac1. 2004, Pubmed
Paranko, Transient coexpression of cytokeratin and vimentin in differentiating rat Sertoli cells. 1986, Pubmed
Paredes, Xenopus: An in vivo model for imaging the inflammatory response following injury and bacterial infection. 2015, Pubmed , Xenbase
Plisov, Mesenchymal-epithelial transition in the developing metanephric kidney: gene expression study by differential display. 2000, Pubmed
Przygodzka, Neuromedin U is upregulated by Snail at early stages of EMT in HT29 colon cancer cells. 2016, Pubmed
Rogatsch, Expression of vimentin, cytokeratin, and desmin in Sertoli cells of human fetal, cryptorchid, and tumour-adjacent testicular tissue. 1996, Pubmed
Schmahl, Sry induces cell proliferation in the mouse gonad. 2000, Pubmed
Sekido, SOX9 is up-regulated by the transient expression of SRY specifically in Sertoli cell precursors. 2004, Pubmed
Sekido, Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer. 2008, Pubmed
Shimabukuro, Fibroblast growth factor-2 stimulates directed migration of periodontal ligament cells via PI3K/AKT signaling and CD44/hyaluronan interaction. 2011, Pubmed
Stosiek, Expression of cytokeratins 8 and 18 in human Sertoli cells of immature and atrophic seminiferous tubules. 1990, Pubmed
Thiery, Epithelial-mesenchymal transitions in development and disease. 2009, Pubmed
Tlapakova, Identification and characterization of Xenopus tropicalis common progenitors of Sertoli and peritubular myoid cell lineages. 2016, Pubmed , Xenbase
Veevers-Lowe, Mesenchymal stem cell migration is regulated by fibronectin through α5β1-integrin-mediated activation of PDGFR-β and potentiation of growth factor signals. 2011, Pubmed
Vincent, A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition. 2009, Pubmed
Xiong, Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition. 2012, Pubmed
Yan, Epithelial to mesenchymal transition in human skin wound healing is induced by tumor necrosis factor-alpha through bone morphogenic protein-2. 2010, Pubmed
Zhou, Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. 2004, Pubmed
Zhou, ZEB1 confers stem cell-like properties in breast cancer by targeting neurogenin-3. 2017, Pubmed